HF
CLVS

HRT Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

HRT Financial’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-130,830
Closed -$235K – 3794
2022
Q2 		$235K Sell
130,830
-962,183
-88% -$1.42M ﹤0.01% 2175
2022
Q1 		$2.21M Buy
1,093,013
+916,306
+519% +$1.8M 0.02% 602
2021
Q4 		$478K Buy
+176,707
New +$653K ﹤0.01% 1929
2021
Q2 		– Sell
-121,490
Closed -$852K – 3758
2021
Q1 		$852K Buy
+121,490
New +$815K 0.01% 1296

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HRT Financial's CLVS Position: Q3 2022 in Review

HRT Financial sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 130,830 shares — an estimated $235K sold.

HRT Financial first reported a position in CLVS in Q1 2021 and held it in 4 quarters. The position peaked at $2.21M in Q1 2022. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • HRT Financial reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 130,830 Clovis Oncology, Inc. shares in Q3 2022, an estimated $235K.
  • HRT Financial first reported a position in Clovis Oncology, Inc. in Q1 2021 and held it in 4 quarters.
  • HRT Financial's Clovis Oncology, Inc. position peaked at $2.21M in Q1 2022.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.